About Us


Caring Deeply.
Working Fearlessly.
Changing Lives.™

Biogen is focused on having the greatest impact and benefit for patients worldwide.

Areas of Focus

Guided by science and driven to improve patients’ lives, our research and development efforts are concentrated on three core ...

The Company

Biogen is one of the world’s leading biotechnology companies, with a focus on developing therapies for neurological, autoimmune and rare diseases.

Biogen Australia

The Australian affiliate markets AVONEX® (interferon beta-1a), TYSABRI® (natalizumab), TECFIDERA® (dimethyl fumarate), PLEGRIDY® (peginterferon beta-1a) and ZINBRYTA® (daclizumab), which are registered and reimbursed for Relapsing Remitting Multiple Sclerosis (RRMS). FAMPYRA® (fampridine) is used to improve walking ability in adults with Multiple Sclerosis.

Excellence at work

We believe that Biogen should be a place where people are proud to work. Everything we do is grounded in our core values of inclusiveness, respect, accountability and commitment to our purpose.